MedinCell is a technological pharmaceutical company, focusing on useful innovation to optimize the efficiency of medical treatments and make them accessible all over the world.
MedinCell and the ICRS are proud to announce an Open Innovation Essay Contest that will be held in conjugation with the ICRS2018 meeting with the objective to promote original thoughts and novel ideas and paths towards solving several of the most urgent questions in the field of Controlled Release.
The Contest is open for graduate and post-graduate students from Israeli Higher Educations Institutes attending the ICRS2018 meeting.
Essay submission deadline: August 19, 2018
First Prize: A fully paid internship in MedinCell’s HQ in Southern France
Second Prize: 2,000 ILS
Third Prize: 1,000 ILS